{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:38:24Z","timestamp":1793291904137,"version":"4.5.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Toxic epidermal necrolysis (TEN) is a rare and severe life-threatening syndrome characterized by apoptosis of keratinocytes resulting in devitalization of the epidermis affecting more than 30% of skin surface. In humans and animals, this condition is mostly triggered by drugs. Identification of the putative agent and its withdrawal are crucial to successful management of a patient with TEN. In this case study, we report the clinical features, histopathological findings and management of a dog with TEN. A 4-year-old intact male French bulldog presented with acute onset of severe lethargy and cutaneous ulcerations on the footpads, scrotum, and hind limbs associated with marked pain. A Stevens-Johnson syndrome\/TEN was suspected and drugs, especially beta-lactams, were withdrawn. Histopathology confirmed the diagnosis of epidermal necrosis. Advanced supportive therapy, pain management and skin care led to rapid remission. Early identification and removal of the suspected medication was crucial to improving TEN prognosis in this dog. Antibiotics (penicillin, ampicillin, cephalexin, and sulfonamides) are frequently involved in adverse cutaneous reactions in dogs. Ideal treatment remains elusive is humans and dogs and this disease has a poor prognosis. Supportive care combined with pain management and treatment of the cutaneous ulcerations is essential.<\/jats:p>","DOI":"10.3389\/fvets.2021.728901","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T13:38:27Z","timestamp":1629466707000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case Report: Positive Outcome of a Suspected Drug-Associated (Immune Mediated) Reaction in a 4-Year-Old Male French Bulldog"],"prefix":"10.3389","volume":"8","author":[{"given":"Line-Alice","family":"Lecru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Combarros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloy","family":"Castilla-Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxence","family":"Delverdier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Cadiergues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charline","family":"Pressanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/ijms17122135","article-title":"Review of toxic epidermal necrolysis","volume":"17","author":"Harris","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/0300985814537530","article-title":"Clinical and microscopic characteristics of canine toxic epidermal necrolysis","volume":"52","author":"Banovic","year":"2015","journal-title":"Vet Pathol."},{"key":"B3","first-page":"80","article-title":"Necrotizing diseases of the epidermis","volume-title":"Skin diseases of the Dog and Cat: Clinical and Histopathologic Diagnosis","author":"Gross","year":"2005"},{"key":"B4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/0738-081X(94)90219-4","article-title":"Cutaneous drug eruptions with epidermal necrosis: a discussion of pathophysiologic and comparative aspects","volume":"12","author":"Mason","year":"1994","journal-title":"Clin Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1939-1676.2012.00927.x","article-title":"Drug hypersensitivity reactions targeting the skin in dogs and cats","volume":"26","author":"Voie","year":"2012","journal-title":"J Vet Intern Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1440-0960.2011.00862.x","article-title":"The management of toxic epidermal necrolysis","volume":"53","author":"Fernando","year":"2012","journal-title":"Aust J Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/vde.12142","article-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: a comparative review","volume":"25","author":"Yager","year":"2014","journal-title":"Vet Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.15406\/mojt.2017.03.00066","article-title":"Drug reaction caused by clavulanate amoxicillin in dogs: report of two cases","volume":"3","author":"Porsani","year":"2017","journal-title":"MOJ Toxicol."},{"key":"B10","first-page":"477","article-title":"Toxic epidermal necrosis","volume-title":"Muller and Kirk's Small Animal Dermatology","author":"Miller","year":"2012"},{"key":"B11","first-page":"53","article-title":"Two cases of toxic epidermal necrolysis caused by delayed hypersensitivity to beta-lactam antibiotics","volume":"3","author":"Romano","year":"1993","journal-title":"J Investig Allergol Clin Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e230144","DOI":"10.1136\/bcr-2019-230144","article-title":"Meropenem-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis in a patient with known type IV penicillin hypersensitivity","volume":"12","author":"Sameed","year":"2019","journal-title":"BMJ Case Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.5455\/2320-6012.ijrms20150227","article-title":"Penicillin induced toxic epidermal necrolysis with secondary impetiginization: a rare case","volume":"3","author":"Ramineni","year":"2015","journal-title":"IJRMS."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e16078","DOI":"10.1097\/MD.0000000000016078","article-title":"Allopurinol-induced toxic epidermal necrolysis featuring almost 60% skin detachment","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine (Baltimore)."},{"key":"B15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s40800-019-0101-z","article-title":"Allopurinol-induced toxic epidermal necrolysis","volume":"6","author":"Buenrostro-Rubio","year":"2019","journal-title":"Drug Saf Case Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol."},{"key":"B17","first-page":"539","article-title":"Immune-mediated dermatoses in domestic-animals - 10 years after - part II","volume":"9","author":"Scott","year":"1987","journal-title":"Comp Cont Educ Pract."},{"key":"B18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/01652176.1995.9694550","article-title":"A retrospective evaluation of adverse reactions to trimethoprim-sulphonamide combinations in dogs and cats","volume":"17","author":"Noli","year":"1995","journal-title":"Vet Q."},{"key":"B19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/0300985816666609","article-title":"Apoptosis as a mechanism for keratinocyte death in canine toxic epidermal necrolysis","volume":"54","author":"Banovic","year":"2017","journal-title":"Vet Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.129.1.92","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2165\/11532540-000000000-00000","article-title":"New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited","volume":"33","author":"Paquet","year":"2010","journal-title":"Drug Saf."},{"key":"B23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther."},{"key":"B24","first-page":"271","article-title":"Toxic epidermal necrolysis in two dogs and a cat","volume":"15","author":"Scott","year":"1979","journal-title":"JAAHA."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/j.bjps.2016.01.034","article-title":"UK guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"69","author":"Creamer","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg."},{"key":"B26","first-page":"24","article-title":"Cyclosporine for SJS\/TEN: a case series and review of the literature","volume":"87","author":"Reese","year":"2011","journal-title":"Cutis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","article-title":"Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"163","author":"Valeyrie-Allanore","year":"2010","journal-title":"Br J Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","article-title":"Treatment of toxic epidermal necrolysis with cyclosporin A","volume":"48","author":"Arevalo","year":"2000","journal-title":"J Trauma."},{"key":"B29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jaad.2011.12.014","article-title":"Toxic epidermal necrolysis: five years of treatment experience from a burn unit","volume":"67","author":"Firoz","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"B30","first-page":"287","article-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis","volume-title":"Dermatology","author":"French","year":"2008"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2021.728901\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T13:38:42Z","timestamp":1629466722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2021.728901\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":30,"alternative-id":["10.3389\/fvets.2021.728901"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2021.728901","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]},"article-number":"728901"}}